ResMed Inc. (RMD) — Financial statements
Income statement, balance sheet, and cash flow for ResMed Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 5,146↑9.8% | 4,685↑10.9% | 4,223↑18.0% | 3,578↑11.9% | 3,197 | |
| Cost of Revenue | 2,091↑3.0% | 2,030↑8.7% | 1,867↑20.2% | 1,554↑14.4% | 1,358 | |
| Gross Profit | 3,055↑15.1% | 2,655↑12.7% | 2,356↑16.4% | 2,024↑10.1% | 1,839 | |
| Operating Expenses | ||||||
| R&D Expenses | 331↑7.7% | 308↑6.9% | 288↑13.4% | 254↑12.6% | 225 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 991↑8.1% | 917↑4.9% | 874↑18.2% | 739↑10.3% | 670 | |
| Other Expenses | 47↓57.3% | 111↑78.2% | 62↑100.0% | 31↓21.8% | 40 | |
| Operating Expenses | 1,370↑2.6% | 1,335↑9.1% | 1,224↑19.5% | 1,024↑9.5% | 935 | |
| Total Costs & Expenses | 3,461↑2.8% | 3,365↑8.9% | 3,091↑19.9% | 2,578↑12.4% | 2,293 | |
| Operating Results | ||||||
| Operating Income | 1,685↑27.7% | 1,320↑16.6% | 1,132↑13.2% | 1,000↑10.7% | 904 | |
| Depreciation & Amortization | 236↑9.1% | 216↑10.0% | 197↑1.4% | 194↑1.2% | 192 | |
| EBITDA | 1,913↑24.8% | 1,534↑12.9% | 1,359↑15.5% | 1,177↑6.6% | 1,104 | |
| EBIT | 1,678↑28.0% | 1,311↑12.8% | 1,162↑18.3% | 983↑7.7% | 912 | |
| Interest & Other Income | ||||||
| Net Interest Income | -13↑72.4% | -46↑3.5% | -47↓112.3% | -22↑5.6% | -24 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 0.36 | |
| Interest Expense | 13↓72.4% | 46↓3.5% | 47↑112.3% | 22↓7.0% | 24 | |
| Non-Operating Income | 10↑4.7% | 9↑130.9% | -30↓273.8% | 17↑301.7% | -9 | |
| Other Income / Expenses | -8↑85.8% | -55↓82.4% | -30↑24.1% | -40↓98.9% | -20 | |
| Income Before Tax | 1,678↑32.6% | 1,265↑14.8% | 1,102↑14.7% | 960↑8.7% | 884 | |
| Income Tax Expense | 277↑13.5% | 244↑19.5% | 204↑12.7% | 181↓55.8% | 409 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 1,401↑37.2% | 1,021↑13.7% | 898↑15.2% | 779↑64.3% | 475 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 1,401↑37.2% | 1,021↑13.7% | 898↑15.2% | 779↑64.3% | 475 | |
| Bottom-Line Net Income | 1,401↑37.2% | 1,021↑13.7% | 898↑15.2% | 779↑64.3% | 475 | |
| EPS (Basic) | 9.55↑37.6% | 6.94↑13.4% | 6.12↑14.6% | 5.34↑63.3% | 3.27 | |
| EPS (Diluted) | 9.51↑37.4% | 6.92↑13.6% | 6.09↑14.9% | 5.30↑63.6% | 3.24 | |
| Weighted Average Shares | 147↓0.2% | 147↑0.2% | 147↑0.5% | 146↑0.5% | 145 | |
| Weighted Average Diluted Shares | 147↓0.1% | 148↑0.1% | 147↑0.3% | 147↑0.4% | 146 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.